Campagno, Keith E.
Lu, Wennan
Jassim, Assraa Hassan
Albalawi, Farraj
Cenaj, Aurora
Tso, Huen-Yee
Clark, Sophia P.
Sripinun, Puttipong
Gómez, Néstor Más
Mitchell, Claire H. http://orcid.org/0000-0002-9784-6672
Funding for this research was provided by:
National Eye Institute (EY-013434, EY-015537, P30 EY001583, T32EY007035)
National Institute of Neurological Disorders and Stroke (T32NS043126)
National Center for Advancing Translational Sciences (TL1TR001880)
Article History
Received: 13 April 2021
Accepted: 25 August 2021
First Online: 20 September 2021
Declarations
:
: All procedures were performed in strict accordance with the National Research Council’s “Guide for the Care and Use of Laboratory Animals” and were approved by the University of Pennsylvania Institutional Animal Care and Use Committee (IACUC) in protocol #803584.
: N/A
: The authors declare that they have no competing interests. Dr. Mitchell is named in a patent describing the use of P2X7 receptor in glaucoma but there is no conflict of interest.